ETV5 and osteoporosis: Consistent with this notion, the systemic treatment of aged mice with ERM, twice a week for eight consecutive weeks, resulted in increased bone mass in the long bones, suggesting potential therapeutic benefits for additional aging-related bone loss disorders, such as osteoporosis.13